SeqOne Genomics Closes €20M Series A Funding
Summary
The round was led by Omnes, Merieux Equity Partners, with participation from the Software Club and existing investors, Elaia and IRDI Capital Investissement. The company intends to use the funds to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in cancer and hereditary disease. The company offers high performance genomic analysis solutions for healthcare providers treating patients suffering from cancer, rare and hereditary diseases as well as pharmaceutical companies developing new therapies. The solution leverages advanced machine learning coupled with the company’s proprietary GeniOS™ genomics operating system to reduce turnaround times and costs while delivering a comprehensive and actionable insights for personalised medicine. The company currently employs over 40 staff, primarily experts in genomic medicine, data science, bioinformatics, software development and regulatory compliance / quality assurance.
Funding
Review available funding amount, funding date, investors, and linked company information related to SeqOne Genomics Closes €20M Series A Funding in the interactive ISVWorld profile.
Classifications
AskAI Classifications
LabelsLinked Companies
